ArticleOncology reports2023

Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways.

Jong Seung Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.